Vidcast:  https://youtu.be/h6zKanQqta8

 

Overall, a booster of the Pfizer mRNA CoVid vaccine produces a 10-fold lower infection rate when boosted and non-boosted populations are compared.  Israeli researchers studied data from 4,621,836 persons over the months of August and September of this year.

 

Looking at the incidence of severe CoVid in various age groups who were either boosted or not, those over age 60 who were boosted were nearly 19 fold (18.7) less likely to develop a severe infection.  Those 40-60 years of age and boosted were 22% less likely to develop that severe CoVid.  For those 60 and above, boosting reduced the death rate 14.7 fold.

 

Since Israel was the first country to implement a large-scale CoVid booster program, their data may help guide all Americans to the conclusion that CoVid boosters at the proper time may be lifesaving. 

 

https://www.medrxiv.org/content/10.1101/2021.10.07.21264626v1.full.pdf

 

#CoVid #booster #mortality